Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate.
HAE Key Statistics
HAE News
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodolo...
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript May 10, 2024 Haemonetics Corporation isn’t one of the 30 most popular stocks among hedge fu...
Revenue: Reported $343 million for Q4 and $1.309 billion for FY 2024, surpassing quarterly estimates of $329.11 million and annual estimates of $1.294 billion....
Analyst ratings
71%
of 7 ratingsMore HAE News
Haemonetics Corporation HAE delivered adjusted earnings per share (EPS) of 90 cents for the fourth quarter of fiscal 2024, up 16.9% year over year. The bottom l...
For the quarter ended March 2024, Haemonetics (HAE) reported revenue of $343.29 million, up 12.8% over the same period last year. EPS came in at $0.90, compared...
Haemonetics (HAE) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0....
On May 6, 2024, Anila Lingamneni, the Executive Vice President and Chief Technology Officer of Haemonetics Corp (NYSE:HAE), sold 2,305 shares of the company. Th...
